This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award for $305,000 supports the development of a bioabsorbable magnesium alloy for maxillofacial fixation. The project aims to create a magnesium-based implant material that can provide temporary bone or tissue support during recovery, then gradually absorb into the body without requiring removal surgeries. Key technical goals include developing an alloy with tunable absorption profiles, understanding how processing affects absorption, and validating a large-animal preclinical model for the novel bioabsorbable implant. The funding will enable the small business awardee, Magsorbeo Biomedical Corp, to demonstrate the feasibility of this approach, which has the potential to improve healthcare outcomes and reduce costs associated with permanent metal implants and complex polymer-based fixation procedures. This STTR Phase I award has a period of performance from March 2025 to March 2026.
Generated 3/18/25, 2:59 AM